MedWatch

IFPMA Director General concerned about future antibiotics: The pipeline looks "grim"

Thomas Cueni, director general at the global trade association IFPMA uses the word "grim" to describe the antibacterial pipeline currently under clinical development. He hopes this picture can be changed through the newly established antibiotics fund, AMR Action Fund.

IFPMA Director General Thomas Cueni Photo: IFPMA / PR

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try MedWatch for 14 days.

Get a trial subscription here.

Do you want a trial subscription with multiple users for yourself and your colleagues?

Read more about your options and find the contact information to our sales team here.

Related articles